NantHealth, Inc.
NHIQ
$0.05
$0.0494,900.00%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Revenue | 64.27M | 68.43M | 67.68M | 67.00M | 65.53M |
| Total Other Revenue | 2.00K | 3.00K | 3.00K | 3.00K | 5.00K |
| Total Revenue | 64.27M | 68.44M | 67.68M | 67.00M | 65.54M |
| Cost of Revenue | 23.37M | 23.74M | 24.24M | 23.85M | 23.39M |
| Gross Profit | 40.90M | 44.69M | 43.44M | 43.15M | 42.14M |
| SG&A Expenses | 54.98M | 62.84M | 64.23M | 62.50M | 60.36M |
| Depreciation & Amortization | 5.50M | 6.64M | 7.79M | 8.93M | 8.93M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 103.21M | 116.52M | 118.75M | 118.33M | 115.76M |
| Operating Income | -38.93M | -48.09M | -51.07M | -51.33M | -50.22M |
| Income Before Tax | -70.64M | -69.37M | -64.33M | -68.10M | -58.77M |
| Income Tax Expenses | -264.00K | -328.00K | -263.00K | -317.00K | 57.00K |
| Earnings from Continuing Operations | -70.37 | -69.04 | -64.07 | -67.78 | -58.82 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -1.00K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | 0.00 |
| Net Income | -70.37M | -69.04M | -64.07M | -67.78M | -58.82M |
| EBIT | -38.93M | -48.09M | -51.07M | -51.33M | -50.22M |
| EBITDA | -29.87M | -42.39M | -45.30M | -45.46M | -44.30M |
| EPS Basic | -8.19 | -8.96 | -8.32 | -8.80 | -7.64 |
| Normalized Basic EPS | -4.93 | -5.64 | -5.24 | -5.51 | -4.77 |
| EPS Diluted | -8.26 | -9.03 | -8.39 | -8.87 | -7.64 |
| Normalized Diluted EPS | -4.93 | -5.64 | -5.24 | -5.51 | -4.77 |
| Average Basic Shares Outstanding | 38.12M | 30.81M | 30.81M | 30.81M | 30.81M |
| Average Diluted Shares Outstanding | 38.12M | 30.81M | 30.81M | 30.81M | 30.81M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |